Loading...
Loading...
Biogen Inc
BIIB shares dropped 16.8% to $320.55. Biogen reported better-than-expected earnings for the second quarter, but the company's revenue missed analysts' estimates. The company also lowered its FY15 forecast. Share volume was six million, quadruple its all-day average
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in